Anne M Mills Selected Research

Carcinoma (Carcinomatosis)

4/2024	Yolk Sac Differentiation in Endometrial Carcinoma: Incidence and Clinicopathologic Features of Somatically Derived Yolk Sac Tumors Versus Carcinomas With Nonspecific Immunoexpression of Yolk Sac Markers.
1/2023	Interobserver Agreement on the Interpretation of Programmed Death-ligand 1 (PD-L1) Combined Positive Score (CPS) Among Gynecologic Pathologists.
11/2020	Expression of the Immune Checkpoints LAG-3 and PD-L1 in High-grade Serous Ovarian Carcinoma: Relationship to Tumor-associated Lymphocytes and Germline BRCA Status.
9/2019	GATA3 Expression in Common Gynecologic Carcinomas: A Potential Pitfall.
12/2018	Concordance levels of PD-L1 expression by immunohistochemistry, mRNA in situ hybridization, and outcome in lung carcinomas.
11/2018	Universal Lynch Syndrome Screening Should be Performed in All Upper Tract Urothelial Carcinomas.
3/2018	Androgen Receptor Expression in Endometrial Carcinoma.
1/2018	The Relationship Between Mismatch Repair Deficiency and PD-L1 Expression in Breast Carcinoma.
11/2017	Mismatch repair status and PD-L1 expression in clear cell carcinomas of the ovary and endometrium.
1/2016	Pure Apocrine Carcinomas Represent a Clinicopathologically Distinct Androgen Receptor-Positive Subset of Triple-Negative Breast Cancers.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Anne M Mills Research Topics

Disease

39	Neoplasms (Cancer) 01/2023 - 03/2011
17	Endometrial Neoplasms (Endometrial Cancer) 01/2023 - 11/2014
11	Carcinoma (Carcinomatosis) 04/2024 - 09/2012
5	Turcot syndrome 01/2023 - 03/2017
5	Hereditary Nonpolyposis Colorectal Neoplasms (Hereditary Nonpolyposis Colorectal Cancer) 01/2023 - 02/2016
5	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2021 - 12/2018
4	Microsatellite Instability 01/2023 - 04/2016
4	Substance Withdrawal Syndrome (Withdrawal Symptoms) 10/2021 - 10/2016
4	Breast Neoplasms (Breast Cancer) 09/2021 - 03/2017
4	Leiomyosarcoma 01/2019 - 04/2011
4	Squamous Intraepithelial Lesions 01/2018 - 02/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2023 - 11/2014
3	Carcinosarcoma 01/2022 - 03/2018
3	Sarcoma (Soft Tissue Sarcoma) 01/2021 - 03/2011
2	Ovarian Neoplasms (Ovarian Cancer) 01/2023 - 01/2018
2	Neurofibrosarcoma (MPNST) 01/2021 - 03/2011
2	Adenocarcinoma 12/2018 - 09/2012
2	Lung Neoplasms (Lung Cancer) 12/2018 - 01/2018
2	Adenosquamous Carcinoma 12/2018 - 09/2012
2	Triple Negative Breast Neoplasms 10/2018 - 01/2016
2	Pancreatic Neoplasms (Pancreatic Cancer) 02/2018 - 01/2018
2	Leiomyoma (Uterine Fibroids) 05/2013 - 05/2013
1	Endodermal Sinus Tumor (Endodermal Sinus Tumors) 04/2024
1	Inflammation (Inflammations) 03/2024
1	Residual Neoplasm 03/2024
1	Melanoma (Melanoma, Malignant) 01/2023
1	Hematologic Neoplasms (Hematological Malignancy) 01/2023
1	Genetic Predisposition to Disease (Genetic Predisposition) 12/2022
1	Hyperplasia 12/2022
1	Obesity 12/2022
1	Polycystic Ovary Syndrome (Syndrome, Stein-Leventhal) 12/2022
1	Anovulation 12/2022
1	Lymphatic Metastasis 03/2021
1	Granulosa Cell Tumor 01/2019
1	Smooth Muscle Tumor 01/2019
1	Carcinoid Tumor (Carcinoid) 12/2018
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2018
1	Small Cell Carcinoma 12/2018
1	Large Cell Carcinoma 12/2018
1	Ductal Carcinoma 01/2018
1	Thrombocytopenia (Thrombopenia) 01/2018
1	Ovarian Epithelial Carcinoma 01/2018
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2018

Drug/Important Bio-Agent (IBA)

11	Proteins (Proteins, Gene)FDA Link 01/2023 - 09/2012
10	LigandsIBA 01/2023 - 03/2017
9	Immune Checkpoint InhibitorsIBA 01/2023 - 03/2017
8	Biomarkers (Surrogate Marker)IBA 01/2023 - 02/2017
5	RNA (Ribonucleic Acid)IBA 01/2021 - 08/2015
4	ParaffinIBA 03/2022 - 08/2015
4	Formaldehyde (Formol)FDA Link 03/2022 - 08/2015
4	Messenger RNA (mRNA)IBA 12/2018 - 05/2017
3	Androgen Receptors (Androgen Receptor)IBA 01/2019 - 01/2016
2	AntigensIBA 01/2023 - 02/2018
2	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2017
2	Progesterone FDA LinkGeneric 12/2022 - 03/2018
2	SmokeIBA 10/2021 - 01/2017
2	AndrogensIBA 01/2019 - 03/2018
2	DioxygenasesIBA 01/2019 - 01/2019
2	EnzymesIBA 01/2019 - 10/2018
2	Hormones (Hormone)IBA 03/2018 - 03/2017
2	Keratin-7 (Cytokeratin 7)IBA 11/2017 - 02/2016
2	Nicotine FDA Link 01/2017 - 10/2016
1	GlypicansIBA 04/2024
1	atezolizumabIBA 03/2024
1	Bevacizumab (Avastin)FDA Link 03/2024
1	PlatinumIBA 01/2023
1	RetinoidsIBA 01/2023
1	pembrolizumabIBA 01/2023
1	Oral ContraceptivesIBA 12/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	human ERBB2 proteinIBA 01/2022
1	Menthol FDA Link 10/2021
1	Galectin 3 (LGALS3)IBA 03/2021
1	Neoplasm Antigens (Tumor Antigens)IBA 01/2021
1	Histocompatibility Antigens Class IIBA 01/2021
1	CollagenIBA 01/2021
1	Proto-Oncogene Proteins c-sis (Platelet Derived Growth Factor B)IBA 01/2021
1	Phosphotransferases (Kinase)IBA 01/2021
1	Coloring Agents (Dyes)IBA 09/2019
1	Dasatinib (BMS 354825)FDA Link 01/2019
1	src-Family KinasesIBA 01/2019
1	AntibodiesIBA 12/2018
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2018
1	Estrogens (Estrogen)FDA Link 03/2018
1	Immunoconjugates (Immunoconjugate)IBA 02/2018
1	Immunotoxins (Immunotoxin)IBA 02/2018
1	Monoclonal AntibodiesIBA 02/2018
1	astacinIBA 02/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	PlectinIBA 01/2018
1	Capsid Proteins (Capsid Protein)IBA 01/2018

Therapy/Procedure

16	Therapeutics 01/2023 - 08/2015
12	Immunotherapy 03/2024 - 11/2017
4	Hysterectomy 12/2022 - 09/2012
2	Intrauterine Devices (Intrauterine Device) 12/2022 - 01/2017
2	Radiotherapy 09/2021 - 03/2011
2	Tobacco Use Cessation Devices 01/2020 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2019 - 11/2017
2	Uterine Myomectomy 05/2013 - 05/2013